Related references
Note: Only part of the references are listed.Circulating Lysophosphatidylcholines, Phosphatidylcholines, Ceramides, and Sphingomyelins and Ovarian Cancer Risk: A 23-Year Prospective Study
Oana A. Zeleznik et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Predictive biomarkers of platinum and taxane resistance using the transcriptomic data of 1816 ovarian cancer patients
Janos Tibor Fekete et al.
GYNECOLOGIC ONCOLOGY (2020)
Inflammation-Induced Tryptophan Breakdown is Related With Anemia, Fatigue, and Depression in Cancer
Lukas Lanser et al.
FRONTIERS IN IMMUNOLOGY (2020)
TOM40 Inhibits Ovarian Cancer Cell Growth by Modulating Mitochondrial Function Including Intracellular ATP and ROS Levels
Wookyeom Yang et al.
CANCERS (2020)
Rho GTPases in Gynecologic Cancers: In-Depth Analysis toward the Paradigm Change from Reactive to Predictive, Preventive, and Personalized Medical Approach Benefiting the Patient and Healthcare
Pavol Zubor et al.
CANCERS (2020)
An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases
Shi-Hui Law et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion (vol 31, pg 4279, 2012)
K. J. Jeong et al.
ONCOGENE (2019)
Gluconeogenesis in cancer cells - Repurposing of a starvation-induced metabolic pathway?
Gabriele Grasmann et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
Proteomics-Derived Biomarker Panel Improves Diagnostic Precision to Classify Endometrioid and High-grade Serous Ovarian Carcinoma
Dylan Z. Dieters-Castator et al.
CLINICAL CANCER RESEARCH (2019)
Wide spectrum targeted metabolomics identifies potential ovarian cancer biomarkers
Szymon Plewa et al.
LIFE SCIENCES (2019)
The landscape of cancer cell line metabolism
Haoxin Li et al.
NATURE MEDICINE (2019)
Insights into Impact of DNA Copy Number Alteration and Methylation on the Proteogenomic Landscape of Human Ovarian Cancer via a Multi-omics Integrative Analysis
Xiaoyu Song et al.
MOLECULAR & CELLULAR PROTEOMICS (2019)
Integrative Proteo-genomic Analysis to Construct CNA-protein Regulatory Map in Breast and Ovarian Tumors
Weiping Ma et al.
MOLECULAR & CELLULAR PROTEOMICS (2019)
Diagnosis of epithelial ovarian cancer using a combined protein biomarker panel
Matthew R. Russell et al.
BRITISH JOURNAL OF CANCER (2019)
DIABLO: an integrative approach for identifying key molecular drivers from multi-omics assays
Amrit Singh et al.
BIOINFORMATICS (2019)
Proteome- wide Tyrosine Phosphorylation Analysis Reveals Dysregulated Signaling Pathways in Ovarian Tumors
Guang Song et al.
MOLECULAR & CELLULAR PROTEOMICS (2019)
UniProt: a worldwide hub of protein knowledge
Alex Bateman et al.
NUCLEIC ACIDS RESEARCH (2019)
The PRIDE database and related tools and resources in 2019: improving support for quantification data
Yasset Perez-Riverol et al.
NUCLEIC ACIDS RESEARCH (2019)
Improving the metabolic fidelity of cancer models with a physiological cell culture medium
Johan Vande Voorde et al.
SCIENCE ADVANCES (2019)
Rewiring of Lipid Metabolism and Storage in Ovarian Cancer Cells after Anti-VEGF Therapy
Matteo Curtarello et al.
CELLS (2019)
High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancer
Stefan Enroth et al.
COMMUNICATIONS BIOLOGY (2019)
Gluconeogenesis in Cancer: Function and Regulation of PEPCK, FBPase, and G6Pase
Zhanyu Wang et al.
TRENDS IN CANCER (2019)
Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment
Kelly L. Singel et al.
JCI INSIGHT (2019)
High molecular weight caldesmon expression in ovarian adult granulosa cell tumour and fibrothecoma
Guohua Yu et al.
HISTOPATHOLOGY (2018)
Proteotranscriptomics Reveal Signaling Networks in the Ovarian Cancer Microenvironment
Thomas Worzfeld et al.
MOLECULAR & CELLULAR PROTEOMICS (2018)
Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment
Chrysi Xintaropoulou et al.
BMC CANCER (2018)
Glutathione in Ovarian Cancer: A Double-Edged Sword
Sofia C. Nunes et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Screening for Ovarian Cancer US Preventive Services Task Force Recommendation Statement
David C. Grossman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis
Jasmine Chong et al.
NUCLEIC ACIDS RESEARCH (2018)
Ovarian Cancer Prevention and Screening
Usha Menon et al.
OBSTETRICS AND GYNECOLOGY (2018)
Spermidine-induced growth inhibition and apoptosis via autophagic activation in cervical cancer
Yu Chen et al.
ONCOLOGY REPORTS (2018)
Spermidine in health and disease
Frank Madeo et al.
SCIENCE (2018)
The carnitine system and cancer metabolic plasticity
Mariarosa Anna Beatrice Melone et al.
CELL DEATH & DISEASE (2018)
JAK2/STAT3 pathway as a therapeutic target in ovarian cancers
Tomoyuki Yoshikawa et al.
ONCOLOGY LETTERS (2018)
The mechanical microenvironment regulates ovarian cancer cell morphology, migration, and spheroid disaggregation
Andrew J. McKenzie et al.
SCIENTIFIC REPORTS (2018)
Clinical analysis of four serum tumor markers in 458 patients with ovarian tumors: diagnostic value of the combined use of HE4, CA125, CA19-9, and CEA in ovarian tumors
Fawen Chen et al.
CANCER MANAGEMENT AND RESEARCH (2018)
The Yet Unrealized Promise of Ovarian Cancer Screening
Charles W. Drescher et al.
JAMA ONCOLOGY (2018)
Oxidative degradation of polyamines by serum supplement causes cytotoxicity on cultured cells
Linlin Wang et al.
SCIENTIFIC REPORTS (2018)
Ovarian Tumor Microenvironment Signaling: Convergence on the Rac1 GTPase
Laurie G. Hudson et al.
CANCERS (2018)
Targeted metabolomic profiling of low and high grade serous epithelial ovarian cancer tissues: a pilot study
Gunjal Garg et al.
METABOLOMICS (2018)
The plasma peptides of ovarian cancer
Jaimie Dufresne et al.
CLINICAL PROTEOMICS (2018)
Sphingolipid metabolism and drug resistance in ovarian cancer
Kelly M. Kreitzburg et al.
CANCER DRUG RESISTANCE (2018)
Integrative Systemic and Local Metabolomics with Impact on Survival in High-Grade Serous Ovarian Cancer
Anna Bachmayr-Heyda et al.
CLINICAL CANCER RESEARCH (2017)
Distinct plasma lipids profiles of recurrent ovarian cancer by liquid chromatography-mass spectrometry
Junnan Li et al.
ONCOTARGET (2017)
Revisiting biomarker discovery by plasma proteomics
Philipp E. Geyer et al.
MOLECULAR SYSTEMS BIOLOGY (2017)
Acetyl-L-carnitine enhances myelination of regenerated fibers of the lateral olfactory tract
Nanae Fukushima et al.
NEUROSCIENCE LETTERS (2017)
Ornithine decarboxylase as a therapeutic target for endometrial cancer
Hong Im Kim et al.
PLOS ONE (2017)
Role of Platelet-Derived Tgfβ1 in the Progression of Ovarian Cancer
Qianghua Hu et al.
CLINICAL CANCER RESEARCH (2017)
Role of ADP receptors on platelets in the growth of ovarian cancer
Min Soon Cho et al.
BLOOD (2017)
Understanding the Intersections between Metabolism and Cancer Biology
Matthew G. Vander Heiden et al.
CELL (2017)
Targeting Ornithine Decarboxylase by α-Difluoromethylornithine Inhibits Tumor Growth by Impairing Myeloid-Derived Suppressor Cells
Cong Ye et al.
JOURNAL OF IMMUNOLOGY (2016)
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
Hui Zhang et al.
CELL (2016)
Persistent Activation of NF-κB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage
Andrea Sau et al.
CELL STEM CELL (2016)
Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors
Matthew F. Buas et al.
GYNECOLOGIC ONCOLOGY (2016)
g:Profiler-a web server for functional interpretation of gene lists (2016 update)
Juri Reimand et al.
NUCLEIC ACIDS RESEARCH (2016)
LC-MS Based Sphingolipidomic Study on A2780 Human Ovarian Cancer Cell Line and its Taxol-resistant Strain
Hao Huang et al.
SCIENTIFIC REPORTS (2016)
Activation of Phosphatidylcholine-Specific Phospholipase C in Breast and Ovarian Cancer: Impact on MRS-Detected Choline Metabolic Profile and Perspectives for Targeted Therapy
Franca Podo et al.
FRONTIERS IN ONCOLOGY (2016)
Quantitative Profiling of Single Formalin Fixed Tumour Sections: proteomics for translational research
Christopher S. Hughes et al.
SCIENTIFIC REPORTS (2016)
The extracellular matrix in epithelial ovarian cancer - a piece of a puzzle
Angela Cho et al.
FRONTIERS IN ONCOLOGY (2015)
Insulin-like growth factor I and risk of epithelial invasive ovarian cancer by tumour characteristics: results from the EPIC cohort
J. Ose et al.
BRITISH JOURNAL OF CANCER (2015)
Acquired cisplatin resistance in human ovarian A2780 cancer cells correlates with shift in taurine homeostasis and ability to volume regulate
Belinda Halling Sorensen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2014)
Targeting JAK1/STAT3 Signaling Suppresses Tumor Progression and Metastasis in a Peritoneal Model of Human Ovarian Cancer
Wei Wen et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Fibroblast Growth Factor Receptor 3 Interacts with and Activates TGFβ-Activated Kinase 1 Tyrosine Phosphorylation and NFkB Signaling in Multiple Myeloma and Bladder Cancer
Lisa Salazar et al.
PLOS ONE (2014)
Platelet Effects on Ovarian Cancer
Ashley N. Davis et al.
SEMINARS IN ONCOLOGY (2014)
Proteomics Analysis for Finding Serum Markers of Ovarian Cancer
Yushan Cheng et al.
BIOMED RESEARCH INTERNATIONAL (2014)
The role of phosphatidylcholine and choline metabolites to cell proliferation and survival
Neale D. Ridgway
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2013)
Identification of Five Serum Protein Markers for Detection of Ovarian Cancer by Antibody Arrays
Weidong Jiang et al.
PLOS ONE (2013)
Biological functions of sphingomyelins
J. Peter Slotte
PROGRESS IN LIPID RESEARCH (2013)
Ovarian Cancer: Biomarker Proteomic Diagnosis in Progress
Yong Zhang et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2012)
Transforming Growth Factor-Beta-Induced Protein (TGFBI)/(βig-H3): A Matrix Protein with Dual Functions in Ovarian Cancer
Miranda P. Ween et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Proteotoxic stress of cancer: Implication of the heat-shock response in oncogenesis
Chengkai Dai et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer
Q. Sheng et al.
BRITISH JOURNAL OF CANCER (2011)
Enhanced tryptophan degradation in patients with ovarian carcinoma correlates with several serum soluble immune activation markers
Barbara Sperner-Unterweger et al.
IMMUNOBIOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Platelet Adhesion and Degranulation Induce Pro-Survival and Pro-Angiogenic Signalling in Ovarian Cancer Cells
Karl Egan et al.
PLOS ONE (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene
Chad A. Hall et al.
CANCER RESEARCH (2010)
Activation of Phosphatidylcholine Cycle Enzymes in Human Epithelial Ovarian Cancer Cells
Egidio Iorio et al.
CANCER RESEARCH (2010)
Cell culture metabolomics: applications and future directions
Miroslava Cuperlovic-Culf et al.
DRUG DISCOVERY TODAY (2010)
Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis
C. E. Holmes et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Regulation of apoptosis-inducing factor-mediated, cisplatin-induced apoptosis by Akt
X. Yang et al.
BRITISH JOURNAL OF CANCER (2008)
Phosphatidylcholine-specific phospholipase C activation in epithelial ovarian cancer cells
Francesca Spadaro et al.
CANCER RESEARCH (2008)
Shared principles in NF-κB signaling
Matthew S. Hayden et al.
CELL (2008)
Diagnostic markers for early detection of ovarian cancer
Irene Visintin et al.
CLINICAL CANCER RESEARCH (2008)
ERK-dependent MKP-1-mediated cisplatin resistance in human ovarian cancer cells
Juan Wang et al.
CANCER RESEARCH (2007)
Neutrophil-mediated maturation of chemerin: A link between innate and adaptive immunity
V Wittamer et al.
JOURNAL OF IMMUNOLOGY (2005)
Ovarian cancer, the coagulation pathway, and inflammation
XP Wang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
Serum protein markers for early detection of ovarian cancer
G Mor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?
SCL Koh et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2001)
Share Paper
